Search

everythinglearnresearchcommunity

for

Search:↓

Surgical face-lifts are more effective, but fractional radiofrequency is a good, less invasive alternative for treating skin laxity.

Aromatase gene variation may increase female hair loss risk.

Men with enlarged prostates often have more severe baldness.

Endocrine therapies for cancer significantly increase the risk of hair loss.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

58% of men aged 30-50 have hair loss, with severity increasing with age.

The combination therapy significantly improved Riehl’s melanosis in patients without serious side effects.

Over half of the adult women with acne in the study had higher than normal levels of male hormones, especially DHEA.

5-alpha reductase inhibitors are generally safe but can cause sexual side effects and require patient education on risks.

A specific gene variant is linked to a higher risk of hair loss from chemotherapy in breast cancer patients.

Balding people may have higher heart disease risk.

The conclusion is that there might be a link between certain types of baldness and prostate cancer, which could be due to shared hormonal pathways.

Platelet-rich plasma treatment significantly increased hair diameter and density, stopped hair fall, and boosted hair growth in men with hair loss, with no reported side effects.

Minoxidil works faster and is more cost-effective for treating hair loss, but platelet-rich plasma microneedling can be an alternative for those who can't use minoxidil.

Identical twins had different symptoms because one had more cells with an extra chromosome fragment in different tissues.

StemMACS media is better for growing therapeutic stem cells than PowerStem media.

Oxymetazoline cream 1.0% effectively reduces rosacea redness, and using baseline photos improves assessment accuracy.

Trichoscopy effectively diagnoses early female hair loss, but may need scalp biopsy for confirmation.

A woman's hair mostly regrew after hair loss from the COVID-19 vaccine with treatment.

Early treatment of fibrosing alopecia in a pattern distribution may improve outcomes.

The Brigham Eyelash Tool for Alopecia (BELA) is a reliable way to measure eyelash loss in alopecia areata patients.

Lower melatonin levels are linked to more skin aging.

The conclusion is that more hair loss (androgenetic alopecia) is linked to larger prostate size, suggesting hair loss could be an early sign of benign prostatic hyperplasia.

The research explored how children in school view peers with alopecia areata.

Hormone therapy might be a proactive alternative to watchful waiting for early-stage prostate cancer, potentially improving survival without aggressive treatment downsides.

A standardized scoring system is needed to improve model reliability for predicting hair loss in brain tumor patients treated with proton therapy.

Xenobiotic-free progenitor cells improve wound healing and blood vessel formation.

DHL-HisZnNa may help reduce hair loss from chemotherapy, but more research is needed.

A new method improves betulin delivery in experiments, showing promise against certain tumors.

PRP is more effective than minoxidil for treating male pattern baldness.